These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25286682)

  • 1. [DAB2IP expression in bladder transitional cell carcinoma and its correlation with clinical outcome].
    Zhu JN; Wu KJ; Guan ZF; Liu LX; Ning ZY; Zhou JC; Wang XY; Fan JH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):591-4. PubMed ID: 25286682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 expression in bladder transitional cell carcinoma and its relationship with clinicopathological features.
    Li Y; Chen M; Yuan J; Zhou X; He W; Zu X; Qi L
    Urol Int; 2014; 92(2):157-63. PubMed ID: 23988662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
    Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival.
    Jou YC; Tsai YS; Chen SY; Hsieh HY; Tsai HT; Tzai TS
    Virchows Arch; 2016 Jun; 468(6):733-40. PubMed ID: 27003158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].
    Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC; Liu GY; Ma HB; Lin WQ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2710-3. PubMed ID: 18167251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.
    Shen YJ; Kong ZL; Wan FN; Wang HK; Bian XJ; Gan HL; Wang CF; Ye DW
    Cancer Sci; 2014 Jun; 105(6):704-12. PubMed ID: 24684735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
    Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
    Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma.
    Li Z; Qi F; Miao J; Zu X; He W; Wang L; Qi L
    Arch Med Res; 2010 Nov; 41(8):606-10. PubMed ID: 21199729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells].
    Zhang K; Wang W; Wu K; Ding C; Zhu J; DU Y; Guan Z; Wang X; Fan J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):668-676. PubMed ID: 28502307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of brain‑specific angiogenesis inhibitor‑1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma.
    Tian D; Hu H; Sun Y; Tang Y; Lei M; Liu L; Han R; Wu C
    Mol Med Rep; 2015 Sep; 12(3):4522-4529. PubMed ID: 26129954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of MUC1 and distribution of tumor-infiltrating dentritic cells in human bladder transitional cell carcinoma].
    Xiang ST; Zhou SW; Guan W; Liu JH; Ye ZQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1114-8. PubMed ID: 16174576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis.
    Zhang H; Qi F; Cao Y; Chen M; Zu X
    Med Sci Monit; 2014 May; 20():812-7. PubMed ID: 24834983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The mRNA expression of platelet-derived endothelial cell growth factor of bladder transitional cell carcinoma and its relation to invasiveness].
    Li G; Zhang YF; Ding Q; Wen DG; Yan CY
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):30-2. PubMed ID: 15059350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of low malignant bladder transitional cell carcinoma: a current perspective.
    Wang HT; Chang JW
    Histol Histopathol; 2005 Jan; 20(1):147-53. PubMed ID: 15578434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].
    Shen HW; Yi L; Wang XM; Yao MJ; Deng JW; Fang JZ; Li MN
    Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.
    Li W; Wang Y; Tan S; Rao Q; Zhu T; Huang G; Li Z; Liu G
    Med Sci Monit; 2018 Oct; 24():7178-7185. PubMed ID: 30296252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential expression of hyaluronic acid synthase family in human bladder transitional cell carcinoma and its clinical significance].
    Cai JL; Li M; Na YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):121-5. PubMed ID: 21575480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
    Zhang H; Guo Y; Song Y; Shang C
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):49-55. PubMed ID: 27878359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.